Annual Drug Patent Expirations for FARYDAK
Farydak is a drug marketed by Secura and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
Drug patent litigation for FARYDAK.
This drug has one hundred and six patent family members in forty-eight countries.
The generic ingredient in FARYDAK is panobinostat lactate. One supplier is listed for this compound. Additional details are available on the panobinostat lactate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
